Singapore markets close in 4 hours 54 minutes

Aptevo Therapeutics Inc. (APVO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9600+0.2493 (+35.08%)
At close: 04:00PM EDT
1.2291 +0.27 (+28.03%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.45M
Enterprise value -8.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.28
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.28

Trading information

Stock price history

Beta (5Y monthly) 4.93
52-week change 3-98.74%
S&P500 52-week change 323.57%
52-week high 380.9600
52-week low 30.6700
50-day moving average 33.7558
200-day moving average 311.7797

Share statistics

Avg vol (3-month) 3393.99k
Avg vol (10-day) 3852.39k
Shares outstanding 53.59M
Implied shares outstanding 63.59M
Float 8532.01k
% held by insiders 10.11%
% held by institutions 11.23%
Shares short (15 Apr 2024) 4145.61k
Short ratio (15 Apr 2024) 40.32
Short % of float (15 Apr 2024) 49.09%
Short % of shares outstanding (15 Apr 2024) 49.06%
Shares short (prior month 15 Mar 2024) 428.86k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 327 Mar 2020
Ex-dividend date 4N/A
Last split factor 21:44
Last split date 306 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-61.12%
Return on equity (ttm)-123.53%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.31M
Net income avi to common (ttm)-18.65M
Diluted EPS (ttm)-67.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.9M
Total cash per share (mrq)31.69
Total debt (mrq)6.08M
Total debt/equity (mrq)49.74%
Current ratio (mrq)2.64
Book value per share (mrq)27.62

Cash flow statement

Operating cash flow (ttm)-11.73M
Levered free cash flow (ttm)-12.38M